• 2011 to 2017 Saw Increase in Spending on DMTs for MS drugs
    January 16, 2020
    From 2011 to 2017, there was an increase in gross annual expenditures on multiple sclerosis (MS) disease-modifying therapies (DMTs), with increased spending mainly driven by increases in per-prescription costs, according to a study published online Januar
PharmaSources Customer Service